AIC
ELDN icon

AWM Investment Company’s Eledon Pharmaceuticals ELDN Stock Holding History

AWM Investment Company’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.39M Hold
1,100,000
– – 0.38% 64
2025
Q4 		$1.66M Buy
+1,100,000
New +$2.61M 0.16% 90
2025
Q3 		– Sell
-1,100,473
Closed -$2.98M – 105
2025
Q2 		$2.98M Hold
1,100,473
– – 0.33% 70
2025
Q1 		$3.73M Hold
1,100,473
– – 0.51% 54
2024
Q4 		$4.53M Buy
+1,100,473
New +$4.34M 0.55% 53
2015
Q1 		– Sell
-617
Closed -$1.47M – 137
2014
Q4 		$1.47M Buy
+617
New +$1.46M 0.2% 98

Other funds holding ELDN

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $712M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
CCM
Catalio Capital Management New York $479M AUM 140.7% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

AWM Investment Company's ELDN Position: Q1 2026 in Review

AWM Investment Company held its Eledon Pharmaceuticals (ELDN) position steady in Q1 2026 at 1,100,000 shares worth $3.39M. The position accounts for 0.38% of the portfolio, ranked #64.

AWM Investment Company first reported a position in ELDN in Q4 2014 and has held it in 6 quarters since. The position peaked at $4.53M in Q4 2024. 121 funds tracked by Wall St. Rank hold ELDN as of Q1 2026.

  • AWM Investment Company held 1,100,000 shares of Eledon Pharmaceuticals worth $3.39M as of Q1 2026.
  • AWM Investment Company left its Eledon Pharmaceuticals share count unchanged in Q1 2026.
  • Eledon Pharmaceuticals made up 0.38% of AWM Investment Company's portfolio in Q1 2026, its #64 holding.
  • AWM Investment Company first reported a position in Eledon Pharmaceuticals in Q4 2014 and has held it in 6 quarters since.
  • AWM Investment Company's Eledon Pharmaceuticals position peaked at $4.53M in Q4 2024.
  • 121 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q1 2026.

Based on AWM Investment Company's 13F filing for Q1 2026, filed 15 May 2026.